Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
Advances in antibody engineering have led to the generation of more innovative antibody drugs, such as bispecific antibodies (bsAbs). Following the success associated with blinatumomab, bsAbs have attracted enormous interest in the field of cancer immunotherapy. By specifically targeting two differe...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
China Anti-Cancer Association
2023-03-01
|
| coleção: | Cancer Biology & Medicine |
| Assuntos: | |
| Acesso em linha: | https://www.cancerbiomed.org/content/20/3/181 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|